1. Home
  2. IDYA vs DRVN Comparison

IDYA vs DRVN Comparison

Compare IDYA & DRVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$34.38

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Logo Driven Brands Holdings Inc.

DRVN

Driven Brands Holdings Inc.

HOLD

Current Price

$14.90

Market Cap

2.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDYA
DRVN
Founded
2015
1972
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Automotive Aftermarket
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.4B
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
IDYA
DRVN
Price
$34.38
$14.90
Analyst Decision
Strong Buy
Buy
Analyst Count
13
8
Target Price
$49.18
$20.43
AVG Volume (30 Days)
943.7K
1.0M
Earning Date
02-12-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$214,834,000.00
$2,439,296,000.00
Revenue This Year
$2,662.86
N/A
Revenue Next Year
N/A
$5.95
P/E Ratio
N/A
N/A
Revenue Growth
5377.66
18.60
52 Week Low
$13.45
$13.44
52 Week High
$37.08
$19.74

Technical Indicators

Market Signals
Indicator
IDYA
DRVN
Relative Strength Index (RSI) 52.00 51.05
Support Level $33.11 $14.67
Resistance Level $34.45 $15.68
Average True Range (ATR) 1.14 0.36
MACD -0.08 -0.04
Stochastic Oscillator 44.14 36.00

Price Performance

Historical Comparison
IDYA
DRVN

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About DRVN Driven Brands Holdings Inc.

Driven Brands Holdings Inc is an automotive services company in North America. Its platform provides high-quality services to an extensive range of retail and commercial customers. The company provides an extensive range of core consumer and commercial automotive needs, including paint, collision, glass, and repair services, as well as a variety of high-frequency services, such as oil changes and car washes. The company segments include: Maintenance, Car Wash, Paint, Collision & Glass, and Platform Services. It derives maximum revenue from Maintenance Segment. Geographically, the company operates into United States, Canada and Rest of the World.

Share on Social Networks: